
  
    
      
        Background_NNP
        Although_IN the_DT role_NN of_IN the_DT osteoclast_NN in_IN bone_NN resorption_NN
        is_VBZ becoming_VBG better_RBR understood_VBN [_NN 1_CD ]_NN ,_, much_JJ remains_VBZ to_TO be_VB
        learned_VBN about_IN osteoclastogenesis_NNS and_CC the_DT exact_JJ mechanism_NN of_IN
        action_NN of_IN anti-resorbing_JJ agents_NNS on_IN the_DT functional_JJ
        osteoclast_NN ._. The_DT anti-resorbing_JJ agent_NN 17_CD β-estradiol_JJ is_VBZ
        especially_RB noteworthy_JJ because_IN of_IN the_DT association_NN of_IN its_PRP$
        decline_NN at_IN menopause_NN with_IN the_DT development_NN of_IN postmenopausal_NN
        osteoporosis_NNS ._. As_IN previously_RB noted_VBN by_IN Liu_NNP and_CC Howard_NNP ,_, the_DT
        underlying_VBG cellular_JJ changes_NNS responsible_JJ the_DT increased_VBN bone_NN
        formation_NN which_WDT follows_VBZ estrogen_NN administration_NN are_VBP still_RB
        not_RB well_RB characterized_VBN [_NN 2_CD ]_NN ._.
        In_IN the_DT present_JJ report_NN we_PRP report_VBP findings_NNS on_IN alterations_NNS
        in_IN osteoclast_NN morphology_NN following_VBG long_JJ term_NN administration_NN
        of_IN high_JJ doses_NNS of_IN 17_CD β-estradiol_JJ to_TO B_NNP 6_CD D_NNP 2_CD F_NN 1_CD mice_NNS ._. Development_NNP
        of_IN osteosclerosis_NNS and_CC the_DT disappearance_NN of_IN the_DT marrow_NN space_NN
        in_IN these_DT estrogen-treated_JJ mice_NNS is_VBZ an_DT interesting_JJ and_CC useful_JJ
        model_NN since_IN marrow_NN stromal_NN cells_NNS not_RB only_RB contain_VB the_DT
        precursors_NNS for_IN osteogenic_JJ cell_NN lineages_NNS ,_, but_CC they_PRP also_RB
        exert_VB important_JJ effects_NNS on_IN osteoclastogenesis_NNS and_CC
        lymphopoiesis_NNS ,_, and_CC modulate_VBP the_DT effects_NNS of_IN some_DT systemic_JJ
        factors_NNS of_IN bone_NN turnover_NN ._. Osteoclasts_NNP ,_, as_RB well_RB as_IN
        osteoblasts_NNS ,_, possess_VBP estrogen_NN receptors_NNS [_NN 3_CD ,_, 4_CD ,_, 5_CD ,_, 6_CD ]_NN ._.
        Hematopoietic_NNP cells_NNS also_RB influence_VBP osteogenic_JJ cell_NN
        differentiation_NN ,_, and_CC some_DT evidence_NN suggests_VBZ that_WDT mature_VBP
        lymphocytes_NNS influence_VBP osteoclast_NN and_CC osteoblast_NN function_NN ._.
        In_IN the_DT estrogen-treated_JJ mouse_NN model_NN used_VBN in_IN the_DT studies_NNS
        reported_VBD here_RB ,_, natural_JJ killer_NN (_( NK_NNP )_) cells_NNS ,_, which_WDT rely_VBP upon_IN
        an_DT intact_JJ bone_NN marrow_NN for_IN full_JJ marrow_NN maturation_NN ,_, are_VBP
        arrested_VBN in_IN a_DT nonlytic_JJ state_NN [_NN 7_CD ]_NN ;_: since_IN marrow_NN space_NN is_VBZ
        lessened_JJ due_NN to_TO the_DT osteosclerosis_NNS ,_, the_DT spleen_NN provides_VBZ the_DT
        source_NN for_IN T_NN and_CC B_NNP cells_NNS and_CC macrophages_NNS ._.
        The_DT objective_NN of_IN the_DT present_JJ study_NN was_VBD to_TO assess_VB the_DT
        functional_JJ state_NN of_IN osteoclasts_NNS in_IN estrogen-treated_JJ mice_NNS by_IN
        determining_VBG if_IN osteoclasts_NNS retained_VBD tartrate-resistant_JJ acid_NN
        phosphatase_NN activity_NN (_( TRAP_NNP )_) and_CC normal_JJ ultrastructural_NN
        features_NNS ._.
      
      
        Results_NNS
        Radiographic_NNP examination_NN of_IN excised_VBD specimens_NNS from_IN
        control_NN and_CC estradiol-treated_JJ mice_NNS confirmed_VBD the_DT presence_NN
        of_IN osteosclerosis_NNS in_IN the_DT femurs_NNS of_IN estradiol-treated_JJ mice_NNS ._.
        Diaphyseal_NNP cortices_NNS were_VBD prominent_JJ in_IN the_DT midshaft_NN of_IN
        control_NN specimens_NNS (_( Figure_NN 1_CD Aand_NNP 1_CD C_NNP )_) ,_, but_CC could_MD not_RB be_VB
        identified_VBN in_IN specimens_NNS from_IN estradiol-treated_JJ animals_NNS
        (_( Figure_NN 1_CD B_NNP ,_, 1_CD Dand_NNP 1_CD E_NNP )_) ._. These_DT changes_NNS were_VBD not_RB due_JJ to_TO
        differences_NNS in_IN radiographic_JJ technique_NN since_IN control_NN and_CC
        estradiol-treated_JJ femurs_NNS shown_VBN in_IN Figure_NN 1_CD were_VBD exposed_VBN
        side-by-side_RB on_IN the_DT same_JJ film_NN ._.
        Histologic_NNP examination_NN also_RB confirmed_VBD osteosclerotic_JJ
        features_NNS in_IN femurs_NNS from_IN estradiol-treated_JJ mice_NNS ._. Specimens_NNP
        from_IN estradiol-treated_JJ mice_NNS contained_VBD only_RB small_JJ regions_NNS of_IN
        bone_NN marrow_NN (_( Fig_NNP ._. 2_LS B_NNP )_) in_IN contrast_NN to_TO control_VB bones_NNS (_( Figure_NN
        2_CD A_DT )_) ._. Since_IN the_DT normal_JJ ,_, pre-estradiol_JJ treatment_NN endosteal_NN
        margin_NN could_MD still_RB be_VB histologically_RB identified_VBN on_IN these_DT
        specimens_NNS ,_, specimens_NNS were_VBD evaluated_VBN with_IN quantitative_JJ
        histomorphometry_NN by_IN first_JJ measuring_NN the_DT old_JJ ,_, normal_JJ marrow_NN
        area_NN and_CC then_RB measuring_VBG the_DT small_JJ marrow_NN cavity_NN areas_NNS
        present_JJ at_IN time_NN of_IN harvest_NN ._. On_IN average_JJ 86_CD %_NN of_IN mid-shaft_JJ
        marrow_NN space_NN was_VBD replaced_VBN by_IN bone_NN in_IN estradiol-treated_JJ mice_NNS
        at_IN 8_CD weeks_NNS (_( p_NN <_NN 0_CD ._. 0001_CD control_NN vs_NNS
        estradiol-treated_JJ )_) ._.
        Osteoclasts_NNP (_( Ocl_NNP )_) present_JJ in_IN both_DT control_NN and_CC
        estradiol-treated_JJ mice_NNS showed_VBD positive_JJ localization_NN of_IN TRAP_NNP
        (_( Figure_NN 2_CD C_NNP )_) ._. In_IN contrast_NN to_TO the_DT close_JJ apposition_NN of_IN Ocl_NNP to_TO
        the_DT bone_NN surface_NN seen_VBN in_IN control_NN specimens_NNS ,_, in_IN
        estradiol-treated_JJ animals_NNS Ocl_NNP extended_VBD away_RB from_IN the_DT bone_NN
        surface_NN with_IN little_JJ bone_NN contact_NN (_( Figure_NN 2_CD D_NNP )_) ._. In_IN order_NN to_TO
        further_VB investigate_VB this_DT observation_NN ,_, transmission_NN electron_NN
        microscopy_NN was_VBD performed_VBN to_TO examine_VB the_DT fine_NN structure_NN of_IN
        the_DT Ocl_NNP in_IN estradiol-treated_JJ and_CC control_NN specimens_NNS ._.
        Figure_NN 3_CD Aillustrates_NNP the_DT normal_JJ ultrastructural_NN
        appearance_NN of_IN an_DT Ocl_NNP from_IN a_DT control_NN femur_NN ;_: note_NN the_DT normal_RB
        ruffled_VBN border_NN and_CC snug_NN apposition_NN of_IN the_DT Ocl_NNP to_TO the_DT bone_NN
        surface_NN ._. Ocl_NNP from_IN estradiol-treated_JJ animals_NNS ,_, however_RB ,_,
        frequently_RB showed_VBD only_RB one_CD margin_NN of_IN the_DT cell_NN perimeter_NN
        involved_VBN with_IN small_JJ areas_NNS of_IN ruffed_JJ border_NN formation_NN ,_, with_IN
        the_DT remainder_NN of_IN the_DT cell_NN surface_NN displaying_VBG a_DT smooth_JJ
        profile_NN (_( Fig_NNP ._. 3_LS B_NNP )_) ._. Some_DT Ocl_NNP from_IN estradiol-treated_JJ animals_NNS
        had_VBD no_DT ruffled_VBN borders_NNS in_IN spite_NN of_IN the_DT appearance_NN of_IN some_DT
        attempt_NN to_TO form_VB sealing_VBG podosome_NN regions_NNS (_( Fig_NNP ._. 3_LS C_NNP )_) ._.
      
      
        Discussion_NNP
        The_DT present_JJ study_NN indicated_VBD that_IN severe_JJ changes_NNS in_IN Ocl_NNP
        morphology_NN are_VBP associated_VBN with_IN the_DT cells_NNS '_POS inability_NN to_TO
        carry_VB out_IN resorption_NN in_IN the_DT osteosclerotic_JJ
        estradiol-treated_JJ mouse_NN ._. Although_IN osteoclasts_NNS retained_VBD TRAP_NNP
        activity_NN ,_, ultrastructural_NN alterations_NNS were_VBD identified_VBN in_IN
        estradiol-treated_JJ animals_NNS in_IN both_DT the_DT sealing_VBG patterns_NNS of_IN
        osteoclasts_NNS against_IN the_DT bone_NN surface_NN and_CC in_IN altered_VBN brush_NN
        border_NN morphology_NN ._. Proper_JJ sealing_VBG of_IN the_DT osteoclast_NN against_IN
        the_DT bone_NN surface_NN and_CC a_DT functional_JJ brush_NN border_NN are_VBP two_CD
        ultrastructural_NN components_NNS believed_VBN to_TO be_VB of_IN major_JJ
        importance_NN in_IN Ocl_NNP function_NN ._. The_DT ultrastructural_NN alterations_NNS
        identified_VBN in_IN estrogen-treated_JJ mice_NNS were_VBD very_RB likely_JJ the_DT
        cellular_JJ functional_JJ basis_NN for_IN the_DT decreased_VBN resorption_NN and_CC
        development_NN of_IN osteosclerosis_NNS in_IN estrogen-treated_JJ mice_NNS ._.
        Osteoclast_NNP function_NN and_CC ultrastructural_NN morphology_NN have_VBP
        been_VBN shown_VBN to_TO be_VB highly_RB responsive_JJ to_TO anti-resorbing_JJ agents_NNS
        such_JJ as_IN ethane-_NN 1_CD -_: hydroxy-_NN 1_CD ,_, 1_CD -_: diphosphonate_NN (_( EHDP_NNP )_) [_NN 8_CD ,_, 9_CD ]_NN ,_,
        dichloromethylene_NN diphosphanate_NN (_( Cl_NNP 
        2_CD MDP_NNP )_) [_NN 10_CD ]_NN ,_, calcitonin_NN [_NN 11_CD ,_, 12_CD ,_, 13_CD ]_NN ,_,
        other_JJ anti-resorptive_JJ agents_NNS ,_, such_JJ as_IN mithramycin_NN [_NN 14_CD ]_NN ,_,
        and_CC to_TO gallium_NN nitrate_NN [_NN 15_CD ]_NN ._.
        Although_IN histochemical_JJ TRAP_NNP localization_NN provides_VBZ an_DT
        accurate_JJ and_CC sensitive_JJ histologic_JJ method_NN for_IN identification_NN
        of_IN Ocl_NNP ,_, understanding_NN osteoclastogenesis_NNS and_CC Ocl_NNP function_NN
        remain_VBP a_DT challenging_VBG area_NN of_IN bone_NN research_NN ._. The_DT current_JJ
        understanding_NN of_IN Ocl_NNP function_NN is_VBZ that_IN the_DT Ocl_NNP seals_NNS its_PRP$
        perimeter_NN along_IN the_DT bone_NN surface_NN by_IN means_NNS of_IN the_DT podosome_NN [_NN
        16_CD ,_, 17_CD ,_, 18_CD ]_NN ._. Within_IN this_DT sealed_JJ margin_NN ,_, projections_NNS from_IN
        the_DT cytoplasm_NN form_NN the_DT ruffled_VBN border_NN ,_, a_DT specialized_JJ
        Ocl-extracellular_NNP space_NN in_IN which_WDT bone_NN resorption_NN occurs_VBZ ._. In_IN
        the_DT present_JJ study_NN in_IN the_DT mouse_NN ,_, differentiation_NN of_IN
        osteoclast_NN progenitors_NNS appears_VBZ to_TO be_VB dependent_JJ on_IN the_DT
        direct_JJ interaction_NN of_IN bone_NN marrow_NN stromal_NN cells_NNS with_IN Ocl_NNP
        precursor_NN cells_NNS [_NN 19_CD ,_, 20_CD ]_NN ._. Recent_JJ data_NNS of_IN Baylink_NNP [_NN 21_CD ]_NN and_CC
        Linkhart_NNP [_NN 22_CD ]_NN provide_VB evidence_NN that_IN two_CD inbred_JJ strains_NNS of_IN
        mice_NNS with_IN different_JJ bone_NN densities_NNS may_MD have_VB fundamental_JJ
        differences_NNS in_IN bone_NN resorption_NN (_( not_RB bone_NN formation_NN )_) ,_, and_CC
        that_IN genes_NNS affecting_VBG the_DT bone_NN marrow_NN Ocl_NNP precursor_NN
        population_NN may_MD contribute_VB to_TO relative_JJ differences_NNS in_IN the_DT
        C_NNP 57_CD BL_NNP /_NN 6_CD J_NNP and_CC C_NNP 3_CD H_NNP /_NN HeJ_NNP strains_NNS ._. In_IN vivo_NN and_CC in_IN vitro_NN studies_NNS
        of_IN avian_NN osteoclasts_NNS led_VBD Pederson_NNP et_CC al_NN to_TO suggest_VB that_DT
        modulation_NN of_IN the_DT Ocl_NNP response_NN to_TO estrogen_NN may_MD be_VB
        controlled_VBN by_IN alterations_NNS in_IN the_DT Ocl_NNP estrogen_NN receptor_NN
        level_NN [_NN 3_CD ]_NN ._.
        Maturation_NNP of_IN osteoclasts_NNS from_IN their_PRP$ macrophage_NN
        precursors_NNS requires_VBZ marrow_NN stromal_NN cells_NNS or_CC their_PRP$
        osteoblast_NN progeny_NN as_IN shown_VBN by_IN Udagawa_NNP et_CC al_NN [_NN 23_CD ]_NN ._. These_DT
        cells_NNS produce_VBP macrophage_NN colony-stimulating_JJ factor_NN (_( M-CSF_NNP )_)
        and_CC the_DT receptor_NN for_IN activation_NN of_IN nuclear_JJ factor_NN kappa_NN b_SYM
        (_( NF-_NNP 
        k_NN B_NNP )_) (_( RANK_NNP )_) ligand_NN (_( RANKL_NNP )_) ._. M-CSF_NNP is_VBZ
        essential_JJ for_IN macrophage_NN maturation_NN ,_, but_CC formation_NN of_IN
        osteoclasts_NNS also_RB requires_VBZ contact_NN between_IN osteoclast_NN
        precursors_NNS and_CC stromal_NN cells_NNS or_CC osteoblasts_NNS [_NN 23_CD ]_NN ._. As_IN
        described_VBN by_IN Hofbauer_NNP et_CC al_NN [_NN 24_CD ]_NN ,_, the_DT quantity_NN of_IN bone_NN
        resorbed_JJ depends_VBZ on_IN the_DT balance_NN between_IN expression_NN of_IN RANKL_NNP
        and_CC of_IN its_PRP$ inhibitor_NN ,_, osteoprotegerin_NN (_( OPG_NNP )_) ._. Hofbauer_NNP et_CC al_NN
        suggest_VBP that_IN the_DT stimulation_NN of_IN the_DT pool_NN of_IN M-CSF_NNP
        precursors_NNS to_TO committed_VBN osteoclastogenesis_NNS by_IN RANKL_NNP may_MD be_VB
        one_CD of_IN the_DT central_JJ pathophysiologic_JJ pathways_NNS involved_VBN in_IN
        increasing_VBG the_DT number_NN of_IN osteoclasts_NNS in_IN osteoporosis_NNS ._.
        Futures_NNS studies_NNS of_IN the_DT estrogen-treated_JJ mouse_NN model_NN are_VBP
        needed_VBN which_WDT are_VBP designed_VBN to_TO address_VB osteoclastogenesis_NNS and_CC
        osteoprotegerin_NN (_( OPG_NNP )_) secretion_NN by_IN osteoblasts_NNS ._. OPG_NNP is_VBZ
        currently_RB hypothesized_VBN to_TO be_VB an_DT important_JJ paracrine_NN
        mediator_NN of_IN the_DT antiresorptive_JJ action_NN of_IN estrogen_NN on_IN bone_NN
        cells_NNS [_NN 25_CD ]_NN ._. In_IN osteoblast_NN cell_NN lines_NNS exposed_VBN to_TO estrogen_NN ,_,
        OPG_NNP mRNA_NN and_CC protein_NN levels_NNS were_VBD increased_VBN compared_VBN to_TO
        controls_NNS ._. Hofbauer_NNP et_CC al_NN have_VBP suggested_VBN that_DT estrogen_NN may_MD
        exert_VB its_PRP$ anti-resorptive_JJ effects_NNS by_IN enhancement_NN of_IN OPG_NNP
        secretion_NN by_IN osteoblasts_NNS [_NN 11_CD ]_NN ._.
        Future_JJ studies_NNS should_MD also_RB assess_VB the_DT temporal_JJ
        development_NN of_IN functional_JJ changes_NNS in_IN the_DT osteoclast_NN
        populations_NNS during_IN estrogen_NN treatment_NN ,_, and_CC the_DT patterns_NNS of_IN
        osteoclast_NN death_NN with_IN special_JJ attention_NN to_TO apoptosis_NNS ._.
        Estradiol_NNP has_VBZ been_VBN shown_VBN to_TO modulate_VBP IL-_NNP 1_CD action_NN on_IN human_JJ
        osteoclasts_NNS in_IN vitro_NN ;_: estrogen_NN administration_NN inhibited_VBD
        IL-_NNP 1_CD -_: mediated_JJ cytokine_NN (_( IL-_NNP 8_CD )_) mRNA_NN induction_NN and_CC caused_VBN
        increased_VBN Ocl_NNP apoptosis_NNS [_NN 26_CD ]_NN ._. When_WRB avian_NN Ocl_NNP were_VBD exposed_VBN
        to_TO estradiol_NN in_IN vitro_NN ,_, the_DT Ocl_NNP plasma_NN membrane_NN became_VBD
        depolarized_JJ and_CC there_EX was_VBD a_DT marked_VBD decrease_NN in_IN potential_JJ ,_,
        suggesting_VBG that_DT estrogen_NN may_MD regulate_VB osteoclasts_NNS through_IN
        ion_NN channel_NN activities_NNS [_NN 27_CD ]_NN ._. Estradiol_NNP has_VBZ also_RB been_VBN shown_VBN
        to_TO inhibit_VB acid_NN production_NN in_IN avian_NN Ocl_NNP [_NN 28_CD ]_NN ._. The_DT human_JJ
        pre-_NN Ocl_NNP cell_NN line_NN FLG_NNP 29_CD ._. 1_LS has_VBZ specific_JJ binding_JJ sites_NNS to_TO
        17_CD β-estradiol_JJ on_IN the_DT cell_NN surface_NN ,_, and_CC estradiol_NN exposure_NN
        increases_VBZ the_DT cellular_JJ pH_NN ,_, cAMP_NN ,_, cGMP_NN and_CC intracellular_NN
        calcium_NN [_NN 29_CD ]_NN ._.
        In_IN vivo_NN work_NN by_IN Jilka_NNP et_CC al_NN has_VBZ shown_VBN that_IN Il-_NNP 6_CD can_MD
        prevent_VB the_DT bone_NN loss_NN associated_VBN with_IN ovariectomy_NN in_IN the_DT
        mouse_NN model_NN [_NN 30_CD ]_NN ._. Girasole_NNP et_CC al_NN have_VBP recently_RB shown_VBN that_DT
        production_NN of_IN IL-_NNP 6_CD is_VBZ inhibited_VBD in_IN vitro_NN by_IN exposure_NN of_IN
        marrow_NN cells_NNS to_TO 17_CD β-estradiol_JJ ;_: cultures_NNS of_IN mouse_NN bone_NN cells_NNS
        showed_VBD suppressed_VBN osteoclast_NN development_NN when_WRB exposed_VBN to_TO
        either_CC 17_CD β-estradiol_JJ or_CC a_DT neutralizing_VBG antibody_NN to_TO Il-_NNP 6_CD [_NN
        31_CD ]_NN ._. Future_NNP in_IN vivo_NN studies_NNS combining_VBG estradiol_NN and_CC
        selected_VBN interleukins_NNS may_MD further_VB elucidate_NN how_WRB the_DT network_NN
        of_IN signals_NNS from_IN the_DT marrow_NN microenvironment_NN influences_VBZ both_DT
        Ocl_NNP development_NN and_CC Ocl_NNP function_NN ._.
      
      
        Conclusions_NNP
        Findings_NNP extend_VB our_PRP$ understanding_NN of_IN osteoclast_NN
        structure_NN and_CC function_NN in_IN the_DT mouse_NN exposed_VBN in_IN vivo_NN to_TO high_JJ
        doses_NNS of_IN estrogen_NN ._. Ultrastructural_NNP examination_NN showed_VBD that_IN
        osteoclasts_NNS from_IN estrogen-treated_JJ mice_NNS were_VBD unable_JJ to_TO seal_VB
        against_IN the_DT bone_NN surface_NN and_CC were_VBD unable_JJ to_TO form_VB ruffled_VBN
        borders_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        B_NNP 6_CD D_NNP 2_CD F_NN 1_CD mice_NNS were_VBD selected_VBN for_IN this_DT study_NN based_VBN upon_IN the_DT
        following_VBG criteria_NNS ._. The_DT C_NNP 57_CD BL_NNP /_NN 6_CD mouse_NN is_VBZ positive_JJ for_IN the_DT
        NK_NNP 1_CD ._. 1_CD epitope_NN but_CC from_IN previous_JJ unpublished_JJ data_NNS we_PRP found_VBD
        that_IN the_DT C_NNP 57_CD BL_NNP /_NN 6_CD responded_VBD poorly_RB to_TO estradiol_NN ._. From_IN
        previous_JJ hybrid_JJ resistance_NN studies_NNS we_PRP had_VBD historical_JJ data_NNS
        that_IN the_DT B_NNP 6_CD D_NNP 2_CD F_NN 1_CD mouse_NN would_MD be_VB positive_JJ for_IN the_DT NK_NNP 1_CD ._. 1_CD
        epitope_NN and_CC respond_VB well_RB to_TO the_DT estradiol_NN ._. B_NNP 6_CD D_NNP 2_CD F_NN 1_CD male_JJ mice_NNS
        aged_VBN 4_CD -_: 5_CD weeks_NNS were_VBD implanted_VBN for_IN at_IN least_JJS 12_CD weeks_NNS with_IN
        silastic_JJ tubing_VBG filled_VBN with_IN 15_CD mg_NN 17_CD β-estradiol_JJ [_NN 32_CD ,_, 33_CD ,_,
        34_CD ,_, 35_CD ]_NN ;_: age-matched_JJ controls_NNS received_VBD empty_JJ tubing_VBG ._. NK_NNP
        cytolytic_JJ functions_NNS disappeared_VBD in_IN estradiol-treated_JJ mice_NNS
        by_IN 8_CD weeks_NNS ._. Previous_JJ work_NN with_IN the_DT model_NN by_IN Roubinian_NNP et_CC al_NN
        showed_VBD that_DT administration_NN of_IN 5_CD -_: 6_CD ._. 5_LS mg_NN estradiol_NN by_IN this_DT
        method_NN returned_VBD estrogen_NN levels_NNS to_TO normal_JJ in_IN ovariectomized_JJ
        mice_NNS for_IN more_JJR than_IN 3_CD months_NNS [_NN 36_CD ]_NN ._. Seaman_NNP et_CC al_NN has_VBZ also_RB
        reported_VBN that_DT administration_NN 15_CD mg_NN estradiol_NN in_IN this_DT model_NN
        was_VBD capable_JJ of_IN raising_VBG estradiol_NN to_TO 9_CD times_NNS the_DT normal_JJ
        level_NN [_NN 37_CD ,_, 38_CD ]_NN ._.
        At_IN 8_CD -_: 18_CD weeks_NNS post-implantation_JJ ,_, euthanasia_NN was_VBD
        performed_VBN (_( CO_NNP 
        2_CD inhalation_NN )_) and_CC femurs_NNS were_VBD harvested_VBN
        from_IN 13_CD control_NN and_CC 33_CD estradiol-treated_JJ mice_NNS ._.
        Cross-sections_NNP of_IN the_DT femur_NN and_CC sections_NNS of_IN femoral_NN
        metaphyses_NNS and_CC epiphyses_NNS were_VBD studied_VBN ._. For_IN light_JJ
        microscopy_NN ,_, specimens_NNS were_VBD either_CC fixed_VBN in_IN 10_CD %_NN neutral_JJ
        buffered_JJ formalin_NN ,_, decalcified_JJ and_CC embedded_VBN in_IN paraffin_NN or_CC
        processed_VBN non-decalcified_JJ and_CC embedded_VBN in_IN methyl_NN
        methacrylate_NN ._. For_IN ultrastructural_NN studies_NNS ,_, specimens_NNS were_VBD
        fixed_VBN in_IN Karnovsky_NNP 's_POS fixative_JJ ,_, post-fixed_JJ in_IN osmium_NN
        tetroxide_NN ,_, decalcified_JJ ,_, and_CC embedded_VBN in_IN Spurr_NNP resin_NN ._. Thin_JJ
        sections_NNS were_VBD prepared_VBN and_CC grids_NNS were_VBD stained_JJ with_IN uranyl_NN
        acetate_NN and_CC lead_VB citrate_NN ._. Sections_NNP were_VBD viewed_VBN on_IN a_DT
        Phillips_NNP CM_NNP 10_CD transmission_NN electron_NN microscope_NN ._. Light_NNP
        microscopic_JJ sections_NNS were_VBD evaluated_VBN with_IN quantitative_JJ
        histomorphometry_NN using_VBG OsteoMeasure_NNP software_NN (_( OsteoMetrics_NNP ,_,
        Inc_NNP ._. ,_, Decatur_NNP ,_, GA_NNP )_) ._. Tartrate-resistant_NNP acid_NN phosphatase_NN
        (_( TRAP_NNP )_) localization_NN was_VBD performed_VBN to_TO identify_VB osteoclasts_NNS
        with_IN light_JJ microscopy_NN ._. Protocols_NNP were_VBD approved_VBN by_IN the_DT
        appropriate_JJ Institutional_NNP Animal_NNP Care_NNP and_CC Use_NNP
        Committee_NNP ._.
        Statistical_NNP analysis_NN of_IN quantitative_JJ histomorphometric_JJ
        data_NNS used_VBD standard_JJ statistical_JJ methods_NNS ;_: means_VBZ and_CC standard_JJ
        deviations_NNS were_VBD calculated_VBN ._. Unpaired_NNP t-tests_JJ were_VBD used_VBN to_TO
        test_VB for_IN differences_NNS between_IN means_VBZ ;_: a_DT p-value_JJ of_IN <_NN 0_CD ._. 05_CD
        was_VBD considered_VBN statistically_RB significant_JJ ._.
      
    
  
